| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |